Godavari Biorefineries Ltd. submitted its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27) to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were approved by the Board of Directors at its meeting held on August 05, 2026.

Financial Performance (Consolidated)

  • Total Income: ₹559.9 crore
  • EBITDA: ₹2.6 crore (includes other income)
  • PAT: Loss of ₹(19.3) crore
  • EBITDA Growth: 11.4% year-over-year (YoY)
  • EBITDA Margin: Improved from 8.9% in Q1 FY26
  • Finance Costs: Reduced by 9.0% YoY to ₹13.9 crore (from ₹15.3 crore in Q1 FY26)

Operational Highlights

  • Bio-based Chemicals Business: Delivered 53% revenue growth with healthy margin expansion and improved profitability.
  • Ethanol Capacity Expansion: Commissioned a 200 KLPD grain-based distillery at Sameerwadi, increasing total ethanol capacity to 800 KLPD.
  • Patent: Secured an Indian patent for a cost-effective process to manufacture branched alcohols.

Drug Discovery Pipeline

  • CDSCO Application: Filed with the Central Drugs Standard Control Organization (CDSCO) to initiate preliminary efficacy trials for a lead novel anti-cancer molecule targeting Triple Negative Breast Cancer.
  • Trial Timeline: Trials expected to commence from Q3 FY27, subject to regulatory approvals.
  • Japanese Patent: Granted for the novel anti-cancer molecule.

Management Commentary

Shri Samir Somaiya, Chairman and Managing Director, stated that Q1 FY27 marked strategic execution and operational milestones. The company strengthened its integrated platform through capacity expansion, enhancing feedstock flexibility and creating a more resilient ethanol business. The bio-based chemicals business showed robust growth due to debottlenecking initiatives and focus on higher-value specialty products. The company's strategic priorities include expanding the high-value bio-based chemicals portfolio, strengthening partnerships, commercializing innovation-led products, and enhancing ethanol fungibility to capitalize on India's biofuel landscape.

Investor Relations

Investor relations contacts:

  • MUFG Intime India Pvt. Ltd.: Ms. Prachi Ambre / Mr. Irfan Raeen, Email: prachi.ambre@in.mpms.mufg.com / irfan.raeen@in.mpms.mufg.com

Safe Harbor Statement

The document includes standard forward-looking statements disclaimer noting that future performance is based on assumptions and subject to risks including industry downtrends, economic changes, tax laws, litigation, exchange rate fluctuations, and other factors. The company does not guarantee fulfillment of these statements and undertakes no obligation to update them.